P2X7 antagonists (Affectis/Merck Serono)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP2X7 antagonists (Affectis/Merck Serono)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsCentral Nervous System Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffectis Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaAffectis Pharmaceuticals Ag
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Infections

Other Information

ATC CodeN/A
Related LinksN/A